BMRN - Company ID 0001048477
BIOMARIN PHARMACEUTICAL INC (BMRN) reported net income of $348.90M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | $348.90M | -18.3% |
| FY 2024 | $426.90M | +154.7% |
| FY 2023 | $167.60M | +18.4% |
| FY 2022 | $141.60M | +320.9% |
| FY 2021 | -$64.10M | -107.5% |
| FY 2020 | $854.03M | +3681.1% |
| FY 2019 | -$23.85M | +69.1% |
| FY 2018 | -$77.21M | +34.0% |
| FY 2017 |
BIOMARIN PHARMACEUTICAL INC (BMRN) reported net income of $348.90M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, BIOMARIN PHARMACEUTICAL INC's net income grew from -$53.84M to $348.90M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$117.04M |
| +81.4% |
| FY 2016 | -$630.21M | -266.8% |
| FY 2015 | -$171.80M | -28.2% |
| FY 2014 | -$133.97M | +24.0% |
| FY 2013 | -$176.35M | -54.2% |
| FY 2012 | -$114.35M | -112.4% |
| FY 2011 | -$53.84M | - |